Page last updated: 2024-08-24

3-iodobenzylguanidine and Cancer of Digestive System

3-iodobenzylguanidine has been researched along with Cancer of Digestive System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergestuen, DS; Khan, MS; Kim, MK; Oberg, K; Rinke, A; Salazar, R; Thirlwell, C; Toumpanakis, C1
Ahmadzadehfar, H; Biersack, HJ; Bucerius, J; Ezziddin, S; Fischer, HP; Logvinski, T; Palmedo, H; Reinhardt, MJ; Yong-Hing, C1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Cancer of Digestive System

ArticleYear
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
    Neuroendocrinology, 2014, Volume: 99, Issue:2

    Topics: 3-Iodobenzylguanidine; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Stomach Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Ultrasonography

2014

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Cancer of Digestive System

ArticleYear
Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:2

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Digestive System Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Somatostatin

2006
chemdatabank.com